nav-left cat-right
cat-right

Clinical Trials in Asia Summit 2009

4th Annual Pharmacovigilance Conference Determining the prospective strategies for Implementing Clinical trials in India & South Asia – Today’s Hottest Market 18th – 20th May 2009, The Park, New Delhi, India   Key Speakers • Chandrashekhar Potkar, Director, Medical and Regulatory Affairs, Pfizer, India • Viraj Rajadhyaksha, Senior Manager, Operations, Planning & Mgmt...

Seegene Receives Approval from Health Canada for I...

Seegene Receives Approval from Health Canada for Its Respiratory Virus Multi-Pathogen Detection Tests Seeplex(R) RV5 and RV12 give Canadian caregivers an effective way to test for a broad range of respiratory viruses and pathogens in one single test. ROCKVILLE, Maryland and SEOUL, Korea, December 3, 2008 — Seegene, Inc., a leader in multi-pathogen diagnostic testing, today announced that it has received a Medical...

First of 100 Arab Human Genomes Sequenced by Saudi...

Press Release from CLC bioRiyadh, Kingdom of Saudi Arabia — September 9, 2008 — An international consortium consisting of Saudi Biosciences, Beijing Genomics Institute Shenzhen, and CLC bio have in a joint effort performed an initial sequencing and analysis of the first Arab human genome, as part of a large project to sequence 100 Arab human genomes to map the unique genetic variations of the Arab...

AstraZeneca, Singapore institutions sign innovativ...

Healthcare company AstraZeneca Plc (AZN: News, Chart, Quote ,AZN.L: News, Chart, Quote ) said Friday that it signed an innovative new partnership with the National Cancer Centre Singapore, or NCCS, and the National University Hospital, or NUH, for development of anti-cancer compounds. The collaboration is spelt out in a Memorandum of Understanding, or MOU. As per the MOU, AstraZeneca and the Singapore institutions...

Seegene and Shimadzu Agree to Join Multi-Pathogen ...

ROCKVILLE, MD and KYOTO, JAPAN–July 28, 2008 – Seegene, Inc. and Shimadzu Corporation today announced a strategic partnership to combine Seegene’s Seeplex(R) multi-pathogen tests with Shimadzu’s MultiNA (1) analytical platform. Under terms of the deal, Shimadzu and Seegene will collaborate on integrating the Seeplex polymerase chain reaction-based tests with Shimadzu’s MultiNA high-speed...

Beijing Genomics Institute signs global site licen...

Aarhus Denmark, July 3rd, 2008 – Beijing Genomics Institute (BGI) has signed a global site license agreement for CLC bio’s Next Generation Sequencing solution, CLC Genomics Workbench. The site license covers all researchers at all BGI sites, both inside and outside of China. Head of Bioinformatics Division at BGI, Ruiqiang Li states, “We have chosen CLC Genomics Workbench as our platform for analyzing...
Page 4 of 11« First...23456...10...Last »